Clinical Trial Update: Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating risk-stratified bladder-sparing modalities for muscle-invasive bladder cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Fudan University | Conditions: Bladder Cancer | Phase 2 | Status: RECRUITING